GSK considers splitting up the group after investor pressure
British pharmaceutical giant GlaxoSmithKline (GSK) is reportedly considering splitting up the company after pressure from investors to spin off its consumer division. Chairman Philip Hampton has reportedly discussed with the group's biggest shareholders about the creation of a standalone pharma and vaccines company. GSK currently operates through pharmaceuticals, vaccines and consumer segments.